<unk>  is a immunologic adjuvant that is FDA approved for the treatment of relapsing forms of multiple sclerosis..   Common adverse reactions include injection site reactions, vasodilatation, rash, dyspnea, and chest pain.
Glatiramer acetate
Riluzole
Fingolimod
Anakinra
Tocilizumab
Atezolizumab
Belatacept
Abatacept